Updates on the Immunotherapy Treatment Paradigm for Mesothelioma

Updates on the Immunotherapy Treatment Paradigm for Mesothelioma

Did you know there is a new standard of care for treating malignant pleural mesothelioma? Join Hedy Lee Kindler, MD, a in a discussion on the latest in the field for immunotherapy treatment in mesothelioma.

This activity is intended for oncologists, pulmonologists, and pathologists.

The goal of this activity is to enable clinicians to personalize therapy for mesothelioma using clinical trial data for mesothelioma treatment regimens.


Learning Objectives:

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical trial data evaluating regimens for the treatment of mesothelioma
  • Have greater competence related to
    • Personalizing therapy for a patient with mesothelioma
  • Demonstrate greater confidence in their ability to
    • Effectively communicate aspects of care to patients with mesothelioma

Approximate Time to Complete: 30 minutes

 

Credit Available: April 13, 2022 - April 13, 2023

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png     

Medscape_EDU-RGB-2x-300.png

 

 

Additional Resources for Clinicans from SITC:

 

 

Course Objectives
Upon completion of this activity, participants will be able to:
  • Have increased knowledge regarding the clinical trial data evaluating regimens for the treatment of mesothelioma.
  • Have greater competence related to personalizing therapy for a patient with mesothelioma.
  • Demonstrate greater confidence in the ability to effectively communicate aspects of care to patients with mesothelioma.
Accreditation Council for Continuing Medical Education (MD/DO)
AMA PRA Category 1 Credit(s)™: 0.50
Accreditation Council for Continuing Medical Education and ABIM Maintenance of Certification
AMA PRA Category 1 Credit(s)™ / ABIM Maintenance of Certification Part 2 Credit: 0.50